Total submissions: 29
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
International Society for Gastrointestinal Hereditary Tumours |
RCV000030220 | SCV000106553 | no known pathogenicity | Lynch syndrome | 2013-09-05 | reviewed by expert panel | research | MAF >1% |
Laboratory for Molecular Medicine, |
RCV000035352 | SCV000059000 | benign | not specified | 2011-12-14 | criteria provided, single submitter | clinical testing | The His718Tyr variant (rs2020873) in MLH1 is present in various populations at f requencies ranging from ~1% to ~16% and is more common individuals with African ancestry. In addition, this variant was reported in patient and control chromoso mes with equal frequncy (Barnetson 2008, Moussa 2011, Weber 1999). Finally, func tional studies have shown the His718Tyr has no discernbile impact on the functio n of the MMR complex (Martinez 2010, Kondo 2003). Therefore this variant is beni gn and not expected to have clinical significance. |
Eurofins Ntd Llc |
RCV000035352 | SCV000110266 | benign | not specified | 2013-09-10 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001081091 | SCV000153886 | benign | Hereditary nonpolyposis colorectal neoplasms | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000035352 | SCV000170301 | benign | not specified | 2013-10-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000157759 | SCV000212715 | benign | Hereditary cancer-predisposing syndrome | 2014-11-18 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Genomic Diagnostic Laboratory, |
RCV000030220 | SCV000257652 | likely benign | Lynch syndrome | 2015-02-05 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000035352 | SCV000303149 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000625495 | SCV000443341 | likely benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2018-01-23 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. |
ARUP Laboratories, |
RCV000035352 | SCV000604233 | benign | not specified | 2018-08-29 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000157759 | SCV000684802 | benign | Hereditary cancer-predisposing syndrome | 2022-01-01 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000625495 | SCV000745683 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2016-11-11 | criteria provided, single submitter | clinical testing | |
Center for Human Genetics, |
RCV000625495 | SCV000781765 | uncertain significance | Colorectal cancer, hereditary nonpolyposis, type 2 | 2016-11-01 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV000157759 | SCV002528721 | benign | Hereditary cancer-predisposing syndrome | 2020-01-30 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000035352 | SCV002550521 | benign | not specified | 2023-08-15 | criteria provided, single submitter | clinical testing | |
Institute for Biomarker Research, |
RCV000157759 | SCV002819149 | benign | Hereditary cancer-predisposing syndrome | 2022-12-20 | criteria provided, single submitter | clinical testing | |
CHEO Genetics Diagnostic Laboratory, |
RCV003149581 | SCV003838873 | benign | Breast and/or ovarian cancer | 2021-10-29 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000625495 | SCV004015877 | benign | Colorectal cancer, hereditary nonpolyposis, type 2 | 2023-07-07 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV000030220 | SCV004843287 | benign | Lynch syndrome | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Biesecker Lab/Clinical Genomics Section, |
RCV000034546 | SCV000043331 | no known pathogenicity | not provided | 2012-07-13 | no assertion criteria provided | research | Converted during submission to Benign. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030220 | SCV000052887 | benign | Lynch syndrome | 2011-10-26 | no assertion criteria provided | clinical testing | |
ITMI | RCV000035352 | SCV000085547 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Pathway Genomics | RCV000144604 | SCV000189931 | benign | Lynch syndrome 1 | 2014-07-24 | no assertion criteria provided | clinical testing | |
Mayo Clinic Laboratories, |
RCV000035352 | SCV000257088 | likely benign | not specified | no assertion criteria provided | clinical testing | ||
Department of Pathology and Laboratory Medicine, |
RCV001353518 | SCV000592442 | likely benign | Carcinoma of colon | no assertion criteria provided | clinical testing | The MLH1 p.His718Tyr variant was identified in 6 of 2626 proband chromosomes (frequency: 0.002) from individuals with sporadic colorectal cancer or suspected HNPCC, none of whom met complete requirements of the Amsterdam or Bethesda criteria (Kim 2004, Kondo 2003, Takahashi 2007, Moussa 2011, Schafmayer 2007). This variant was also identified in 17 of 2254 control chromosomes from the above studies (frequency: 0.008), in the 1000 Genomes Project with a frequency of 0.028, and in the Exome Variant Server ESP Project with a frequency of 0.07 amongst African American alleles, suggesting that this variant may represent a benign polymorphism in certain populations. The variant was also reported in dbSNP (rs2020873) and LOVD. In vitro MMR assays and yeast hybrid-two assays examining the ability of the variant to repair a heteroduplex DNA with mismatch bases found that its activity was similar to that of wildtype (Kondo 2003, Takahashi 2007), suggesting that this is a nonpathogenic alteration. The p.His718 residue is conserved across mammals and computational analyses (PolyPhen, SIFT, AlignGVGD) suggest that the p.His718Tyr variant may impact the protein. However, this information is not predictive enough to assume pathogenicity. In summary, based on the above information, we cannot determine the clinical significance of this variant with certainty at this time, although we would lean towards a more benign role for this variant. In summary, this variant is classified as predicted benign. | |
True Health Diagnostics | RCV000157759 | SCV000788023 | benign | Hereditary cancer-predisposing syndrome | 2017-10-26 | no assertion criteria provided | clinical testing | |
Clinical Genetics, |
RCV000035352 | SCV001922338 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000035352 | SCV001958947 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000035352 | SCV002036958 | benign | not specified | no assertion criteria provided | clinical testing |